{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Nicotinamide Riboside in Cardiac Ischemia-Reperfusion Injury"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Mice were randomised to receive either NR (50 mg/L) or vehicle control."
      },
      "Participants": {
        "score": 1,
        "evidence": "This randomised controlled trial involved C57BL6/N adult male mice."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Mice were randomised to receive either NR (50 mg/L) or vehicle control."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates NR's efficacy in protecting isolated mouse hearts from ischemia-reperfusion (IR) injury."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was infarct size, measured by TTC staining after 90 minutes of reperfusion."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was maintained for outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 16 mice were randomised, with 8 in each group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "NR treatment significantly reduced infarct size compared to control (mean difference = 15%, 95% CI 10% to 20%; p < 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by institutional grants."
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}